All News

coronavirus,COVID,MISC,mask

ACR Updates Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With COVID

Jack Cush, MD

A Task Force from the ACR has provided an updated (version 3) guidance for the diagnosis and management of Multisystem Inflammatory Syndrome in Children (MIS-C), a COVID related condition characterized by fever, inflammation, and multiorgan dysfunction.

Read Article
RheumNow Podcast square

An Ounce of Prevention (2.4.2022)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.  He discusses the GI side effects of IL-17 inhibitors, downstream revenues from rheumatology care and dietary prevention of gout. 

Read Article
vasculitis.Churg-Strauss_syndrome.wikipedia.jpg

ACR/EULAR 2022 Classification Criteria for EGPA

Jack Cush, MD

The 2022 ACR/EULAR revised classification criteria for eosinophilic granulomatosis with polyangiitis (EGPA) have been revised and validated for use in clinical research.

Read Article
ANCA, vasculitis, test

ACR/EULAR 2022 Classification Criteria for Granulomatosis with Polyangiitis

Jack Cush, MD

The ACR/EULAR 2022 revised classification criteria for granulomatosis with polyangiitis (GPA) have been updated with performance characteristics and are validated for use in clinical research.

Read Article
ANCA, vasculitis, test

ACR/EULAR 2022 Classification Criteria for Microscopic Polyangiitis

Jack Cush, MD

The 2022 ACR/EULAR  classification criteria for microscopic polyangiitis (MPA) have been developed, validated and are now ready for use in clinical research.

Read Article
ACR, guidance, guidelines

ACR Newly Revised COVID-19 Vaccine Clinical Guidance for RMD Patients

ACR

The ACR has updated its clinical guidance for the use of COVID-19 vaccination in patients with musculoskeletal disorders (MSK). 

Read Article
RheumNow Podcast square

The Last Word on JAK Inhibitor Safety & 1133 Study (1.28.2022)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  This week a trifecta of Gout reports and the last word on the ORAL Surveillance study...

Read Article
RheumNow Podcast square

Believing is Doing (1.21.2022)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. These reports are about better outcomes in Lupus; fewer Gout flares with T2T and the power of belief. 

Read Article
RheumNow Podcast square

The Overpricing of Drugs (1.14.2022)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. This week we discuss amputations, a $57 billion RA market, an FDA approved drug for Cat arthritis and drug that works in Sjogren's.

Read Article
Join Dr. Alexis Ogdie at RheumNow Live next month, as she leads a panel on RWE & Registries in Psoriatic Arthritis. Attend on-site in Texas or virtually! Invigorate, Instigate and Debate Rheumatology at #RNL2022 https://t.co/aTEWF9VsdN https://t.co/e2W5XpzztN

Links:

Dr. John Cush RheumNow ( View Tweet)
Women Heroes in Rheum: - Barbara Ansell - JIA - Nanna Svartz - SSZ - Gertrude Elion - Nobel Prize for allopurinol, AZA - Tsai-Fan Yu - gout Rx - Mary Betty Stevens - lupus & vasculitis - Marian Ropes - 1st F ARA president - Fionula Brennan - TNFi & more https://t.co/a9tKUyWBBu https://t.co/UsHDpzJ8ma

Links:

Dr. John Cush RheumNow ( View Tweet)
We are excited to announce that Dr. Philip Mease will be joining us at RheumNow Live, leading a presentation and discussion on Axial Psoriatic Arthritis & Fatigue and Central Sensitization. Join the discussion on March 19-20, on site or virtually! https://t.co/3CeULLDgf5 https://t.co/M2ZUoXzlAK

Links:

Dr. John Cush RheumNow ( View Tweet)
We are excited to announce that Dr. Ernest Choy will be joining us at RheumNow Live, leading a presentation on Precision Medicine in Rheumatoid Arthritis. Join the discussion on March 19-20. Invigorate, Instigate and Debate Rheumatology at #RNL2022 https://t.co/4uXQfRvRgc https://t.co/7KcPXadGcY

Links:

Dr. John Cush RheumNow ( View Tweet)
We are excited to announce that Dr. Janet Pope will be joining us at RheumNow Live, leading a presentation on Drug Cycling vs Switching in RA. Join the discussion on March 19-20, on site or virtually! https://t.co/RfWz53vem3 https://t.co/9n1UzFrkVb

Links:

Dr. John Cush RheumNow ( View Tweet)
Who is Your Glue? Surely you have used or heard of “<the person> who was the glue that held the family together”. Read on… https://t.co/CRaWDQaZvk https://t.co/q8KFcxzzDG

Links:

Dr. John Cush RheumNow ( View Tweet)
ONE MILLION DOWNLOADS! We are excited to announce Dr.Cush and the RheumNow podcast recently hit one million downloads! Thank you to all of our listeners-we appreciate you coming back week after week. Find us each week where ever you get your podcasts. https://t.co/AOJCMGZClJ https://t.co/3ImftCnqzw

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Peter Nigrovic asserts the division between pediatric and adult arthritis is senseless and has no firm biologic basis. Instead we should consider pts as sero- positive or negative, Systemci or Spondyloarthropathy. @UTSWRheum https://t.co/zx5oQmUQ6Y
Dr. John Cush RheumNow ( View Tweet)
ASK CUSH ANYTHING! Have a Rheumatology question or case for Dr. Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/LAC6XrYEyN https://t.co/POGHk7Ibq2

Links:

Dr. John Cush RheumNow ( View Tweet)
Register for RheumNow Live, March 19-20, 2022. You can attend RheumNow Live in person in Irving, Texas - or, the comfort of your own home or office. You can also receive CME credit! https://t.co/c7oLLCllM8 https://t.co/EGCGFilnVv

Links:

Dr. John Cush RheumNow ( View Tweet)
New podcast! Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow. This week we discuss amputations, a $57 billion RA market, an FDA approved drug for Cat arthritis and drug that works in Sjogrens. https://t.co/Pg4snhCZyo https://t.co/ruzRs0ypcn https://t.co/zwI8baPEcn

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×